CVE-2023-4421

Description

The NSS code used for checking PKCS#1 v1.5 was leaking information useful in mounting Bleichenbacher-like attacks. Both the overall correctness of the padding as well as the length of the encrypted message was leaking through timing side-channel. By sending large number of attacker-selected ciphertexts, the attacker would be able to decrypt a previously intercepted PKCS#1 v1.5 ciphertext (for example, to decrypt a TLS session that used RSA key exchange), or forge a signature using the victim's key. The issue was fixed by implementing the implicit rejection algorithm, in which the NSS returns a deterministic random message in case invalid padding is detected, as proposed in the Marvin Attack paper. This vulnerability affects NSS < 3.61.

Category

6.5
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.23%
Vendor Advisory mozilla.org
Affected: Mozilla NSS
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-4421?
CVE-2023-4421 has been scored as a medium severity vulnerability.
How to fix CVE-2023-4421?
To fix CVE-2023-4421, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-4421 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-4421 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-4421?
CVE-2023-4421 affects Mozilla NSS.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.